Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
TNF-Related Apoptosis-Inducing Ligand | 28 | 2024 | 195 | 6.360 |
Why?
|
Glioblastoma | 44 | 2024 | 3524 | 6.090 |
Why?
|
Brain Neoplasms | 48 | 2024 | 9177 | 4.400 |
Why?
|
Oncolytic Virotherapy | 17 | 2023 | 521 | 3.880 |
Why?
|
Mesenchymal Stem Cells | 18 | 2024 | 1671 | 3.170 |
Why?
|
Stem Cell Transplantation | 17 | 2016 | 1602 | 2.590 |
Why?
|
Stem Cells | 22 | 2023 | 3538 | 2.520 |
Why?
|
Simplexvirus | 11 | 2023 | 805 | 1.700 |
Why?
|
Glioma | 19 | 2020 | 3523 | 1.680 |
Why?
|
Oncolytic Viruses | 8 | 2023 | 345 | 1.640 |
Why?
|
Mesenchymal Stem Cell Transplantation | 8 | 2022 | 507 | 1.550 |
Why?
|
Thrombospondin 1 | 3 | 2024 | 259 | 1.540 |
Why?
|
Tumor Microenvironment | 12 | 2024 | 3939 | 1.420 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 7 | 2021 | 58 | 1.380 |
Why?
|
Immunotherapy | 15 | 2024 | 4728 | 1.380 |
Why?
|
Cell Line, Tumor | 48 | 2024 | 17149 | 1.370 |
Why?
|
Apoptosis | 25 | 2024 | 9526 | 1.300 |
Why?
|
Interferon-beta | 2 | 2024 | 348 | 1.290 |
Why?
|
Exotoxins | 2 | 2021 | 123 | 1.210 |
Why?
|
Neoplasms | 19 | 2024 | 22389 | 1.090 |
Why?
|
Genes, Transgenic, Suicide | 2 | 2023 | 34 | 1.050 |
Why?
|
Interleukin-13 | 2 | 2021 | 392 | 1.040 |
Why?
|
Genetic Engineering | 8 | 2018 | 936 | 1.040 |
Why?
|
Xenograft Model Antitumor Assays | 18 | 2020 | 3619 | 1.010 |
Why?
|
Mice | 71 | 2024 | 82051 | 0.970 |
Why?
|
Neural Stem Cells | 4 | 2018 | 892 | 0.950 |
Why?
|
Single-Chain Antibodies | 2 | 2024 | 112 | 0.910 |
Why?
|
Neoplastic Stem Cells | 6 | 2024 | 1357 | 0.880 |
Why?
|
Animals | 92 | 2024 | 169424 | 0.880 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2024 | 146 | 0.870 |
Why?
|
Molecular Targeted Therapy | 7 | 2019 | 2834 | 0.860 |
Why?
|
Pseudomonas | 2 | 2021 | 124 | 0.850 |
Why?
|
Herpesvirus 1, Human | 6 | 2023 | 744 | 0.810 |
Why?
|
Mice, Nude | 21 | 2018 | 3635 | 0.810 |
Why?
|
Genetic Vectors | 16 | 2015 | 3417 | 0.810 |
Why?
|
Interleukin-13 Receptor alpha2 Subunit | 1 | 2021 | 9 | 0.770 |
Why?
|
Drug Resistance, Neoplasm | 12 | 2024 | 5342 | 0.730 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2023 | 5708 | 0.670 |
Why?
|
Immunotherapy, Adoptive | 4 | 2023 | 1505 | 0.660 |
Why?
|
Hyaluronoglucosaminidase | 2 | 2020 | 138 | 0.640 |
Why?
|
Cell Movement | 9 | 2020 | 5223 | 0.640 |
Why?
|
Cell Death | 6 | 2023 | 1684 | 0.610 |
Why?
|
Lentivirus | 7 | 2014 | 519 | 0.590 |
Why?
|
Antibodies, Bispecific | 2 | 2017 | 204 | 0.570 |
Why?
|
Neoplasms, Experimental | 2 | 2020 | 1232 | 0.560 |
Why?
|
Gene Expression Regulation, Neoplastic | 11 | 2021 | 8636 | 0.560 |
Why?
|
Tissue Engineering | 3 | 2019 | 1890 | 0.550 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2020 | 452 | 0.550 |
Why?
|
Luminescent Measurements | 6 | 2014 | 342 | 0.550 |
Why?
|
Drug Delivery Systems | 4 | 2016 | 2238 | 0.520 |
Why?
|
Antineoplastic Agents | 13 | 2022 | 13709 | 0.510 |
Why?
|
MicroRNAs | 3 | 2020 | 3806 | 0.510 |
Why?
|
Up-Regulation | 4 | 2020 | 4132 | 0.510 |
Why?
|
Bacterial Toxins | 1 | 2021 | 926 | 0.500 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10269 | 0.500 |
Why?
|
Peptide Elongation Factor 2 | 1 | 2015 | 17 | 0.500 |
Why?
|
Recombinant Fusion Proteins | 4 | 2016 | 3735 | 0.490 |
Why?
|
Neurons | 11 | 2020 | 9504 | 0.490 |
Why?
|
Cancer Vaccines | 1 | 2023 | 1044 | 0.490 |
Why?
|
Humans | 110 | 2024 | 768369 | 0.490 |
Why?
|
Disease Models, Animal | 15 | 2024 | 18390 | 0.470 |
Why?
|
Membrane Glycoproteins | 5 | 2005 | 3710 | 0.460 |
Why?
|
Adenoviridae | 4 | 2020 | 1098 | 0.460 |
Why?
|
Hyaluronic Acid | 3 | 2020 | 489 | 0.450 |
Why?
|
Melanoma, Experimental | 1 | 2017 | 561 | 0.450 |
Why?
|
Down-Regulation | 2 | 2020 | 2942 | 0.450 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2005 | 4362 | 0.450 |
Why?
|
Quinazolinones | 2 | 2019 | 222 | 0.440 |
Why?
|
Luminescent Proteins | 6 | 2012 | 839 | 0.410 |
Why?
|
Microscopy, Fluorescence | 5 | 2012 | 2640 | 0.410 |
Why?
|
Interleukins | 3 | 2012 | 791 | 0.400 |
Why?
|
Triazines | 1 | 2014 | 312 | 0.390 |
Why?
|
Neovascularization, Pathologic | 3 | 2024 | 2643 | 0.390 |
Why?
|
Optical Phenomena | 1 | 2012 | 106 | 0.390 |
Why?
|
Brain | 9 | 2024 | 27439 | 0.390 |
Why?
|
Neoplasm Metastasis | 4 | 2018 | 4931 | 0.390 |
Why?
|
Cell Survival | 9 | 2020 | 5800 | 0.380 |
Why?
|
Genes, Reporter | 5 | 2020 | 1524 | 0.380 |
Why?
|
Transduction, Genetic | 5 | 2014 | 903 | 0.370 |
Why?
|
Medulloblastoma | 2 | 2014 | 681 | 0.360 |
Why?
|
Morpholines | 1 | 2014 | 583 | 0.360 |
Why?
|
Receptors, Death Domain | 2 | 2021 | 31 | 0.340 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2014 | 568 | 0.340 |
Why?
|
Ganciclovir | 3 | 2023 | 255 | 0.330 |
Why?
|
Furans | 1 | 2010 | 201 | 0.330 |
Why?
|
Caspases | 4 | 2018 | 884 | 0.320 |
Why?
|
Viral Proteins | 2 | 2014 | 1802 | 0.320 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3611 | 0.320 |
Why?
|
Apoptosis Regulatory Proteins | 6 | 2020 | 1147 | 0.320 |
Why?
|
Drug Resistance | 1 | 2015 | 1599 | 0.310 |
Why?
|
Cell Proliferation | 9 | 2023 | 10490 | 0.310 |
Why?
|
Cell Adhesion Molecules | 5 | 2014 | 1615 | 0.300 |
Why?
|
Signal Transduction | 13 | 2020 | 23639 | 0.300 |
Why?
|
Cerebellar Neoplasms | 1 | 2012 | 589 | 0.290 |
Why?
|
Antibodies | 1 | 2015 | 2426 | 0.290 |
Why?
|
Tumor Cells, Cultured | 7 | 2019 | 6135 | 0.280 |
Why?
|
Dacarbazine | 2 | 2017 | 560 | 0.280 |
Why?
|
Hydrogels | 1 | 2013 | 745 | 0.280 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11844 | 0.270 |
Why?
|
Thymidine Kinase | 3 | 2023 | 286 | 0.270 |
Why?
|
Immunomodulation | 2 | 2021 | 550 | 0.270 |
Why?
|
Tumor Burden | 4 | 2017 | 1909 | 0.270 |
Why?
|
Diagnostic Imaging | 4 | 2011 | 3543 | 0.270 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2818 | 0.260 |
Why?
|
Premedication | 1 | 2007 | 246 | 0.260 |
Why?
|
Drug Utilization Review | 1 | 2007 | 248 | 0.250 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2067 | 0.250 |
Why?
|
Breast Neoplasms | 6 | 2023 | 21157 | 0.250 |
Why?
|
Melanoma | 2 | 2023 | 5740 | 0.240 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2020 | 720 | 0.240 |
Why?
|
Oligonucleotides, Antisense | 1 | 2007 | 462 | 0.240 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2008 | 618 | 0.240 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1977 | 0.240 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5426 | 0.230 |
Why?
|
Embryonic Stem Cells | 2 | 2009 | 1249 | 0.230 |
Why?
|
Bystander Effect | 2 | 2018 | 89 | 0.230 |
Why?
|
HIV Protease | 1 | 2004 | 98 | 0.220 |
Why?
|
Pyridines | 3 | 2021 | 2888 | 0.220 |
Why?
|
Green Fluorescent Proteins | 4 | 2012 | 2072 | 0.220 |
Why?
|
Killer Cells, Natural | 2 | 2023 | 2207 | 0.210 |
Why?
|
Vesicular Stomatitis | 1 | 2023 | 18 | 0.210 |
Why?
|
Ligands | 2 | 2021 | 3279 | 0.210 |
Why?
|
Transfection | 5 | 2014 | 5767 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2021 | 1409 | 0.200 |
Why?
|
Polycythemia Vera | 1 | 2004 | 161 | 0.200 |
Why?
|
RNA Interference | 2 | 2007 | 2832 | 0.190 |
Why?
|
Caspase 3 | 3 | 2011 | 732 | 0.190 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2007 | 470 | 0.190 |
Why?
|
Neoplasm Transplantation | 4 | 2020 | 2017 | 0.190 |
Why?
|
Mice, SCID | 3 | 2014 | 2633 | 0.190 |
Why?
|
YY1 Transcription Factor | 1 | 2021 | 60 | 0.190 |
Why?
|
Bacterial Proteins | 1 | 2015 | 3861 | 0.190 |
Why?
|
Bioengineering | 1 | 2022 | 100 | 0.180 |
Why?
|
Molecular Imaging | 3 | 2018 | 825 | 0.180 |
Why?
|
Luciferases | 5 | 2005 | 712 | 0.180 |
Why?
|
Immunotoxins | 1 | 2021 | 175 | 0.180 |
Why?
|
Threonine | 1 | 2001 | 274 | 0.180 |
Why?
|
Tumor Suppressor Proteins | 2 | 2021 | 2819 | 0.180 |
Why?
|
Cell Transplantation | 3 | 2011 | 475 | 0.180 |
Why?
|
Enzyme Inhibitors | 2 | 2010 | 3734 | 0.180 |
Why?
|
Cell Differentiation | 4 | 2020 | 11674 | 0.180 |
Why?
|
Combined Modality Therapy | 4 | 2015 | 8559 | 0.170 |
Why?
|
Dendritic Cells | 2 | 2024 | 2753 | 0.170 |
Why?
|
RNA, Small Interfering | 3 | 2010 | 3436 | 0.170 |
Why?
|
Caspase 7 | 2 | 2011 | 50 | 0.170 |
Why?
|
HT29 Cells | 2 | 2017 | 192 | 0.170 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 895 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2024 | 9425 | 0.170 |
Why?
|
Half-Life | 1 | 2020 | 650 | 0.160 |
Why?
|
Serpins | 1 | 2020 | 247 | 0.160 |
Why?
|
bcl-2-Associated X Protein | 1 | 2020 | 282 | 0.160 |
Why?
|
Drug Carriers | 2 | 2014 | 712 | 0.160 |
Why?
|
Nanostructures | 1 | 2024 | 553 | 0.160 |
Why?
|
Gene Transfer Techniques | 1 | 2004 | 1209 | 0.160 |
Why?
|
Leg | 1 | 2004 | 1089 | 0.160 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13589 | 0.150 |
Why?
|
Angiogenesis Inhibitors | 2 | 2024 | 2062 | 0.150 |
Why?
|
Extracellular Matrix | 3 | 2020 | 1737 | 0.150 |
Why?
|
Immunization | 1 | 2023 | 1220 | 0.150 |
Why?
|
Survival Analysis | 3 | 2020 | 10127 | 0.150 |
Why?
|
Pyrimidines | 1 | 2010 | 3050 | 0.150 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2021 | 467 | 0.150 |
Why?
|
Cell Growth Processes | 2 | 2010 | 383 | 0.150 |
Why?
|
Adult Stem Cells | 1 | 2020 | 222 | 0.150 |
Why?
|
HEK293 Cells | 4 | 2017 | 4294 | 0.150 |
Why?
|
Arabidopsis | 1 | 2001 | 469 | 0.150 |
Why?
|
HMGB Proteins | 1 | 2017 | 45 | 0.150 |
Why?
|
Preoperative Care | 1 | 2007 | 2257 | 0.150 |
Why?
|
Receptors, Somatostatin | 1 | 2018 | 138 | 0.140 |
Why?
|
Pulmonary Fibrosis | 1 | 2021 | 507 | 0.140 |
Why?
|
Blotting, Western | 3 | 2012 | 5042 | 0.140 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2020 | 1352 | 0.140 |
Why?
|
Gene Knockdown Techniques | 4 | 2014 | 1609 | 0.140 |
Why?
|
Cell Line | 4 | 2017 | 15610 | 0.140 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2017 | 100 | 0.130 |
Why?
|
Coculture Techniques | 2 | 2010 | 1343 | 0.130 |
Why?
|
HCT116 Cells | 1 | 2017 | 406 | 0.130 |
Why?
|
Vero Cells | 3 | 2014 | 486 | 0.130 |
Why?
|
Virus Replication | 4 | 2023 | 2443 | 0.130 |
Why?
|
Prodrugs | 1 | 2018 | 274 | 0.130 |
Why?
|
Treatment Outcome | 10 | 2022 | 65408 | 0.130 |
Why?
|
Hematopoietic Stem Cells | 1 | 2008 | 3408 | 0.130 |
Why?
|
Immunophenotyping | 1 | 2020 | 1868 | 0.120 |
Why?
|
Fluorescent Dyes | 3 | 2013 | 1924 | 0.120 |
Why?
|
Fluorescence | 2 | 2009 | 760 | 0.120 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2017 | 660 | 0.120 |
Why?
|
Retinoid X Receptors | 1 | 2014 | 91 | 0.120 |
Why?
|
Cell Count | 2 | 2011 | 1834 | 0.120 |
Why?
|
Oncogene Proteins v-erbB | 1 | 2014 | 17 | 0.120 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1104 | 0.120 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 33 | 0.120 |
Why?
|
Nervous System Diseases | 1 | 2005 | 1668 | 0.120 |
Why?
|
Protein Kinases | 1 | 2001 | 1608 | 0.120 |
Why?
|
Receptor, Notch1 | 1 | 2017 | 521 | 0.110 |
Why?
|
Retinoids | 1 | 2014 | 99 | 0.110 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2012 | 2331 | 0.110 |
Why?
|
Positron-Emission Tomography | 4 | 2018 | 6657 | 0.110 |
Why?
|
Injections, Intralesional | 1 | 2014 | 281 | 0.110 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 384 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2072 | 0.110 |
Why?
|
Genomic Instability | 1 | 2017 | 714 | 0.110 |
Why?
|
Ki-67 Antigen | 2 | 2012 | 631 | 0.110 |
Why?
|
Biomimetic Materials | 1 | 2014 | 173 | 0.110 |
Why?
|
Protein Engineering | 1 | 2016 | 549 | 0.100 |
Why?
|
Capsules | 1 | 2013 | 193 | 0.100 |
Why?
|
Dependovirus | 2 | 2008 | 720 | 0.100 |
Why?
|
Benzamides | 2 | 2021 | 1381 | 0.100 |
Why?
|
Liver Neoplasms | 4 | 2014 | 4362 | 0.100 |
Why?
|
Interferon-gamma | 1 | 2020 | 3164 | 0.100 |
Why?
|
Mutation | 3 | 2021 | 30235 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8051 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2020 | 2324 | 0.090 |
Why?
|
Time Factors | 7 | 2012 | 40271 | 0.090 |
Why?
|
Membrane Proteins | 6 | 2020 | 7895 | 0.090 |
Why?
|
Bacteria | 1 | 2022 | 2226 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20232 | 0.090 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 669 | 0.090 |
Why?
|
DNA Damage | 1 | 2020 | 2461 | 0.090 |
Why?
|
Female | 15 | 2024 | 396926 | 0.090 |
Why?
|
Drug Synergism | 1 | 2014 | 1765 | 0.080 |
Why?
|
Neoplasm Invasiveness | 3 | 2012 | 3637 | 0.080 |
Why?
|
Endothelial Cells | 2 | 2014 | 3586 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2910 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2022 | 3076 | 0.080 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1905 | 0.080 |
Why?
|
Luciferases, Renilla | 1 | 2009 | 22 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 2018 | 1251 | 0.080 |
Why?
|
Luciferases, Firefly | 1 | 2009 | 38 | 0.080 |
Why?
|
Immunohistochemistry | 3 | 2024 | 11139 | 0.080 |
Why?
|
Cytokines | 2 | 2022 | 7440 | 0.080 |
Why?
|
Spectroscopy, Near-Infrared | 2 | 2004 | 752 | 0.080 |
Why?
|
Methods | 1 | 2009 | 1067 | 0.080 |
Why?
|
Cisplatin | 1 | 2015 | 1661 | 0.080 |
Why?
|
Cells, Cultured | 4 | 2020 | 19035 | 0.080 |
Why?
|
Transplantation, Heterologous | 3 | 2013 | 2393 | 0.080 |
Why?
|
Fluorouracil | 2 | 2012 | 1656 | 0.070 |
Why?
|
MAP Kinase Signaling System | 2 | 2012 | 1489 | 0.070 |
Why?
|
Models, Molecular | 2 | 2012 | 5441 | 0.070 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2012 | 776 | 0.070 |
Why?
|
Tomography, Optical | 1 | 2008 | 129 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2014 | 958 | 0.070 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 22365 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3832 | 0.070 |
Why?
|
Pandemics | 3 | 2022 | 8751 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 9066 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3105 | 0.070 |
Why?
|
Protein Binding | 2 | 2020 | 9376 | 0.070 |
Why?
|
Transcription Factors | 3 | 2017 | 12176 | 0.070 |
Why?
|
Survival Rate | 1 | 2020 | 12875 | 0.070 |
Why?
|
Craniotomy | 1 | 2011 | 748 | 0.070 |
Why?
|
Pakistan | 1 | 2007 | 298 | 0.060 |
Why?
|
RNA-Binding Proteins | 5 | 2014 | 1885 | 0.060 |
Why?
|
Lung | 2 | 2022 | 10090 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2009 | 647 | 0.060 |
Why?
|
Medical Audit | 1 | 2007 | 454 | 0.060 |
Why?
|
Galactosides | 1 | 2005 | 54 | 0.060 |
Why?
|
Midazolam | 1 | 2007 | 267 | 0.060 |
Why?
|
Gene Expression | 2 | 2014 | 7605 | 0.060 |
Why?
|
Hospitals, University | 1 | 2007 | 569 | 0.060 |
Why?
|
Nervous System Neoplasms | 1 | 2005 | 91 | 0.060 |
Why?
|
Immunoconjugates | 1 | 2012 | 968 | 0.060 |
Why?
|
Molecular Probe Techniques | 1 | 2005 | 111 | 0.060 |
Why?
|
Regenerative Medicine | 1 | 2008 | 311 | 0.060 |
Why?
|
Biocompatible Materials | 1 | 2013 | 1703 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6242 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2017 | 4613 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2014 | 9558 | 0.050 |
Why?
|
Caspase 1 | 1 | 2004 | 227 | 0.050 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 2023 | 93 | 0.050 |
Why?
|
beta-Galactosidase | 1 | 2004 | 575 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2847 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 2007 | 443 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
Argininosuccinate Synthase | 1 | 2022 | 16 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Polyethylene Glycols | 2 | 2022 | 1195 | 0.050 |
Why?
|
Cell Cycle | 1 | 2010 | 2942 | 0.050 |
Why?
|
Formaldehyde | 1 | 2024 | 361 | 0.050 |
Why?
|
Tomography, Emission-Computed | 1 | 2005 | 1123 | 0.050 |
Why?
|
Computer Systems | 1 | 2003 | 470 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2005 | 753 | 0.050 |
Why?
|
HIV Protease Inhibitors | 1 | 2004 | 432 | 0.050 |
Why?
|
Hydrolases | 1 | 2022 | 146 | 0.050 |
Why?
|
Models, Biological | 2 | 2020 | 9505 | 0.050 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2012 | 2823 | 0.050 |
Why?
|
Mutagenesis | 1 | 2005 | 1231 | 0.040 |
Why?
|
Benzodiazepines | 1 | 2007 | 1139 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2004 | 488 | 0.040 |
Why?
|
Disease Progression | 2 | 2020 | 13643 | 0.040 |
Why?
|
Endopeptidases | 1 | 2004 | 772 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5443 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 1142 | 0.040 |
Why?
|
Arabidopsis Proteins | 1 | 2001 | 265 | 0.040 |
Why?
|
Adult | 3 | 2024 | 223528 | 0.040 |
Why?
|
bcl-X Protein | 1 | 2021 | 412 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2005 | 4174 | 0.040 |
Why?
|
Granzymes | 1 | 2020 | 278 | 0.040 |
Why?
|
Bioreactors | 1 | 2020 | 246 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2020 | 343 | 0.040 |
Why?
|
Forecasting | 1 | 2008 | 2950 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9261 | 0.040 |
Why?
|
Electrophysiological Phenomena | 1 | 2020 | 309 | 0.040 |
Why?
|
Arginine | 1 | 2022 | 923 | 0.040 |
Why?
|
Endoplasmic Reticulum | 1 | 2004 | 1129 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3813 | 0.040 |
Why?
|
Genetic Markers | 1 | 2004 | 2604 | 0.040 |
Why?
|
Kinetics | 2 | 2004 | 6347 | 0.040 |
Why?
|
Epitopes | 1 | 2024 | 2523 | 0.040 |
Why?
|
Octreotide | 1 | 2018 | 155 | 0.040 |
Why?
|
Phosphorylation | 2 | 2014 | 8331 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 2750 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2020 | 561 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2007 | 5893 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2022 | 1032 | 0.030 |
Why?
|
Indoles | 1 | 2005 | 1834 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 10784 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 714 | 0.030 |
Why?
|
Injections | 2 | 2013 | 840 | 0.030 |
Why?
|
Radiopharmaceuticals | 2 | 2018 | 2731 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1840 | 0.030 |
Why?
|
Zebrafish | 2 | 2017 | 3038 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2001 | 3594 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 746 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1335 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2005 | 6527 | 0.030 |
Why?
|
Melanoma, Amelanotic | 1 | 2014 | 19 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 1002 | 0.030 |
Why?
|
Doxorubicin | 2 | 2012 | 2229 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2882 | 0.030 |
Why?
|
Xenopus Proteins | 1 | 2017 | 436 | 0.030 |
Why?
|
Mice, Inbred CBA | 1 | 2014 | 438 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1786 | 0.030 |
Why?
|
Diethylnitrosamine | 1 | 2012 | 45 | 0.030 |
Why?
|
Factor XII | 1 | 2012 | 19 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2674 | 0.030 |
Why?
|
Microglia | 1 | 2022 | 1376 | 0.030 |
Why?
|
Polyribosomes | 1 | 2012 | 109 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2017 | 1563 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2415 | 0.030 |
Why?
|
NF-kappa B | 1 | 2021 | 2491 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2009 | 9623 | 0.020 |
Why?
|
Tretinoin | 1 | 2014 | 525 | 0.020 |
Why?
|
Diffusion | 1 | 2013 | 818 | 0.020 |
Why?
|
Cell Lineage | 1 | 2020 | 2575 | 0.020 |
Why?
|
Male | 5 | 2020 | 364761 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2004 | 3038 | 0.020 |
Why?
|
Base Sequence | 1 | 2001 | 12426 | 0.020 |
Why?
|
Feathers | 1 | 2009 | 29 | 0.020 |
Why?
|
Dihydrouracil Dehydrogenase (NADP) | 1 | 2009 | 17 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13447 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2023 | 4948 | 0.020 |
Why?
|
Thymidylate Synthase | 1 | 2009 | 74 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 757 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2013 | 2298 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 17637 | 0.020 |
Why?
|
Integrins | 1 | 2013 | 845 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2010 | 462 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 3042 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2010 | 635 | 0.020 |
Why?
|
Risk Assessment | 1 | 2008 | 24310 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2012 | 12813 | 0.020 |
Why?
|
Fatty Liver | 1 | 2012 | 807 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 2008 | 694 | 0.020 |
Why?
|
Hepatocytes | 1 | 2012 | 1247 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6241 | 0.020 |
Why?
|
Fatty Acids | 1 | 2012 | 1818 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3793 | 0.010 |
Why?
|
Lac Operon | 1 | 2004 | 237 | 0.010 |
Why?
|
Injections, Intraventricular | 1 | 2004 | 227 | 0.010 |
Why?
|
Gene Transfer, Horizontal | 1 | 2004 | 149 | 0.010 |
Why?
|
Radiation, Ionizing | 1 | 2004 | 252 | 0.010 |
Why?
|
Staurosporine | 1 | 2004 | 241 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5803 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2544 | 0.010 |
Why?
|
Rats | 2 | 2010 | 23839 | 0.010 |
Why?
|
Glycoproteins | 1 | 2008 | 2207 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5308 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 36840 | 0.010 |
Why?
|
Antigens, CD | 1 | 2008 | 4022 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2003 | 1427 | 0.010 |
Why?
|
Liver | 1 | 2012 | 7575 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9508 | 0.010 |
Why?
|
Peptides | 1 | 2008 | 4368 | 0.010 |
Why?
|
DNA | 1 | 2009 | 7213 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41782 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20763 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2004 | 14725 | 0.000 |
Why?
|
Aged | 1 | 2020 | 171514 | 0.000 |
Why?
|
Middle Aged | 1 | 2020 | 223406 | 0.000 |
Why?
|